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Abstract
The oxidative damage hypothesis proposed for the function gain of copper, zinc superoxide dismutase (SOD1) maintains
that both mutant and wild-type (WT) SOD1 catalyze reactions with abnormal substrates that damage cellular components
critical for viability of the affected cells. However, whether the oxidative damage of SOD1 is involved in the formation of
aggregates rich in SOD1 or not remains elusive. Here, we sought to explore the oxidative aggregation of WT SOD1 exposed
to environments containing both ascorbate (Asc) and DNA under neutral conditions. The results showed that the WT SOD1
protein was oxidized in the presence of Asc. The oxidation results in the higher affinity of the modified protein for DNA than
that of the unmodified protein. The oxidized SOD1 was observed to be more prone to aggregation than the WT SOD1, and
the addition of DNA can significantly accelerate the oxidative aggregation. Moreover, a reasonable relationship can be
found between the oxidation, increased hydrophobicity, and aggregation of SOD1 in the presence of DNA. The crucial step
in aggregation is neutralization of the positive charges on some SOD1 surfaces by DNA binding. This study might be crucial
for understanding molecular forces driving the protein aggregation.
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Introduction
Copper, zinc superoxide dismutase (SOD1) is a thermostable
32 kDa homodimeric enzyme that is abundant in eukaryotic cells
and normally catalyzes the conversion of superoxide anion to
peroxide hydrogen and dioxygen through cyclical reduction and
oxidation of copper [1]. Its mutation and overexpression does not
result in an increased protection, but rather create a variety of
injurious effects, for example, involvement in the development of
amyotrophic lateral sclerosis (ALS) by inducing motor neuron
death [2–18].
Many hypotheses including aggregation and oxidative damage
have been proposed to explain the toxicity of SOD1 [6,9]. The
aggregation hypothesis maintains that mutant proteins of SOD1
become misfolded and consequently oligomerize into high-
molecular-weight species that end up in proteinaceous inclusions,
and the oligomerized or aggregated proteins are, at some stage in
their formation, selectively toxic to motor neurons [6]. Protein-
aceous inclusions rich in SOD1 have been observed in tissues from
ALS patients, ALS-SOD1 transgenic mice, and in cell culture
models [7–27]. The visible aggregates or inclusions in SOD1-
linked diseases may be one of the pathological hallmarks, and have
been linked to any of the disruptions in cellular functions [6–
12,28,29]. Polymorphous SOD1 aggregates have been shown to
be generated in vitro from WT SOD1 and ALS-associated variants
[30–33]. Moreover, it has been observed in vitro that the negatively
charged species including DNA can induce or accelerate
aggregation of SOD1 in different forms [33,34], as observed for
other proteins [35,36].
The oxidative damage hypothesis maintains that SOD1 of
various forms catalyzes reactions with abnormal substrates such as
H2O2 that damage cellular components (including the protein
itself) critical for viability of the affected cells [6,37,38]. The
oxidative damage requires the involvement of the redox-active
copper bound to SOD1 proteins. Most oxidative damage to SOD1
proteins in vivo was believed to occur by site-specific, metal-
mediated mechanism in which a Fenton reaction of H2O2 with
redox-active metals produces hydroxyl a radical which immedi-
ately oxidizes an amino acid residue in close proximity to the
metal-binding sites and results in enzyme inactivation, oxidative
modification of residues at or near the metal sites, and loss of
metals, likely as observed in vitro [39,40]. However, although there
is increasing evidence indicating that elevated oxidative damage to
SOD1 proteins are present in the tissue of ALS transgenic mice
[37], it is not known currently if the oxidative modification is
involved in the SOD1 aggregation in vivo because a recent study
showed that the SOD1 isolated from the aggregates in several
SOD1 transgenic mouse lines contained primarily full-length
unmodified SOD1 proteins [41]. The in vitro oxidation leads to
destabilization and dissociation of dimeric SOD1 at physiological
concentrations (,40 mM) prior to aggregation [40,42–44]. The
zinc-deficient WT SOD1 and some of its mutants should be prone
to form visible aggregates in vitro upon treatment with ascorbate
(ascorbic acid, Asc) or/and copper salt compared with the WT
holoprotein [42,45].
DNA has been observed to act as a template accelerating the
aggregation of WT SOD1 in vitro under acidic conditions [33]. In
order to support the conclusion, the present study in vitro examines
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and Asc within motor neurons and other cells [46], may accelerate
the aggregation of WT SOD1 in vitro under neutral conditions.
The presence of Asc has been observed to cause oxidative damage
to WT SOD1 proteins under neutral conditions [42]. During
probing the template effect of DNA in WT SOD1 aggregation in
vitro, we have found that the DNA-mediated enrichment of and the
acidic pH-triggered hydrophobic alteration of the SOD1 protein
are two key steps for aggregation [33]. The aggregation of SOD1
is dramatically accelerated by DNA under acidic conditions, but
not under neutral conditions since neutral pH cannot alter the
hydrophobicity of WT SOD1. However, WT SOD1 can also be
enriched by DNA through the electrostatic interactions between
them under neutral conditions [47]. On the other hand, ALS-
linked MT SOD1 proteins have been classified into two groups:
WT-like and metal binding region mutants [7,48]. The WT-like
mutants have a stronger aggregation-prone propensity via the site-
specific oxidation of the copper-coordinated histidine residues by
the reactions of the copper with H2O2 [49], as compared with the
metal binding region mutants [50,51]. Different ALS-associated
mutations promote SOD1 aggregation by essentially distinct
pathways [12]. In essence, the WT SOD1 treated with Asc
behaves like the WT-like mutants because Asc at pharmacologic
concentrations generates H2O2 and Asc radicals through the
metal-dependent reactions in vivo [52], resulting in the conversion
of WT SOD1 into an oxidized forms that resembles the mutant
proteins. The oxidized SOD1 proteins can acquire binding and
toxic properties of ALS-associated mutants [3]. Since the
aggregation-prone propensity of oxidized SOD1 proteins was
observed in vitro to be weak [40,42–44], we examined the
accelerating effect of DNA that acts as a template in the oxidized
WT SOD1 aggregation in vitro.
Results
Asc-Mediated Oxidation of SOD1 in vitro
Based on the previous reports [48,49,52,53], the reactions of
Asc or H2O2 with either copper on proteins (for example SOD1)
or added redox metal ions in the presence of dioxygen are capable
of producing reactive oxygen species (ROS) to oxidize SOD1
proteins under neutral conditions. Here, 0–8 mM Asc (normal
concentrations in neurons and glial cells are 0.5–10 mM [46]) was
used to lead to oxidation of WT SOD1 in vitro in this study.
To investigate the oxidation of WT SOD1, first, the
dependence of oxidation on Asc dose was examined with non-
reducing sodium dodecyl sulfate-polyacrylamide gel electrophore-
sis (SDS-PAGE) at pH 7.4, because WT SOD1 is well known to
be resistant to SDS. The non-reducing SDS-PAGE of SOD1
treated with Asc shows changes in stability upon oxidation. The
observed SOD1 bands corresponding to dimeric and monomeric
forms in gels (Figure 1A) showed that the SOD1 proteins treated
with Asc were increasingly converted into monomers from dimers,
indicating that the WT SOD1 dissociates into monomers upon
oxidation. Obviously, any SOD1 aggregate was not observed in
the SDS-PAGE gels, showing that the SOD1 aggregates, likely
formed under the test conditions, were not SDS-resistant, as
previously observed for the SOD1 proteins of other forms [54–56].
Then, to prove the results described above, we performed two-
dimensional gel electrophoresis experiments on samples treated
with 4 mM Asc. The SOD1 proteins were resolved by isoelectric
focusing (IEF) on an immobilized pH gradient strip after Asc
treatment. The results showed that many protein spots maintain
the same molecular masses (,16 and ,32 kDa for monomer and
dimer, respectively), but show different isoelectric points (, pI
4.8–6.1 for monomer, and pI 5.2–6.2 for dimer, Figure 1B). Here,
the trace of dimeric species only observed in the two-dimensional
gels is ascribed to the presence of 8 M urea in its loading buffer,
which leads to dissociation of dimeric SOD1 into a monomeric
form. The pI values found for the oxidized SOD1 proteins are well
consistent with those found for the oxidatively modified isoforms of
SOD1 (pI 6.3, 6.0, 5.7, and 5.0) extracted from Alzheimer and
Parkinson disease brains [57]. Moreover, the pI for the protein
spots of WT SOD1 treated by H2O2 was observed to be 5.3–5.6
due to the oxidation of its Cys111-SH to Cys111-SO2/3H [58].
Therefore, the differences in pI values might be caused by the
different oxidized products of and the oxidative modification to
Cys-SH groups on the SOD1 protein, as well as by the differences
in the metallation extent of SOD1 protein.
Changes in Hydrophobicity of Oxidized SOD1 Proteins in
the Presence of DNA
The results delineated above reveal that the Asc-containing
environment can lead to oxidation and dissociation of the dimeric
protein. A question arises as to whether or not any change in the
hydrophobicity or tertiary structure of the SOD1 protein appears
upon oxidation, otherwise the oxidized SOD1 proteins cannot
aggregate. Therefore, ANS (8-anilino-1-napthalene-sulfonic acid)
dye binding experiments were performed on the Asc-treated
SOD1 samples with and without DNA. ANS binding, which is a
fluorescence probe that can indicate the disruption and formation
Figure 1. Observations of Asc-mediated WT SOD1 oxidation by
one- and two-dimensional gel electrophoresis. A) Non-reducing
SDS-PAGE gels for observation of Asc dose-dependent SOD1 oxidation.
10 mMS O D 1w a si n c u b a t e da t3 7 uCf o r2hw i t h0 – 8m MA s c .B )2 - D Eg e l s
for observation of pI and molecular mass of the SOD1 protein treated with
Asc. 10 mM SOD1 was incubated with 4 mM Asc at 37uC for 2 h.
doi:10.1371/journal.pone.0012328.g001
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surface area available for binding fluorophores.
First, we determined fluorescence spectra of the ANS added into
samples with and without Asc. The fluorescence spectra of the
ANS added into the samples containing (1) SOD1, and (2) both
SOD1 and ctDNA (Calf thymus DNA) at given levels were
observed to be identical to that of the ANS alone in the same
buffer. The addition of Asc into the SOD1 samples in the absence
of DNA resulted in a slight increase in the ANS fluorescence
(,5%, Figure S1), whereas the addition of DNA led to at least
26% enhancement in emission of the ANS that was added into the
mixture containing SOD1 and Asc under identical conditions
(Figure 2A). These results indicated that (1) the WT SOD1 protein
didn’t show the ANS binding even in the presence of DNA, (2)
ANS can bind to the oxidatively modified SOD1 proteins
regardless of addition of DNA, and (3) the addition of DNA can
further alter the hydrophobicity of oxidized SOD1 proteins.
Therefore, the enhancement in the hydrophobicity of WT SOD1
is caused by the combination of Asc and DNA.
Then, we examined further the effect of Asc dose and incubation
time on the ANS fluorescence. The ANS emission was observed to
be progressively enhanced (Figure 2B) over the Asc dose range (0–
4 mM) in the presence of DNA, showing that increasing doses of
Asc led to exposure of more SOD1 hydrophobic surfaces. On the
other hand, the ANS emission was also significantly enhanced over
incubation time (0–72 h, Figure 2C), demonstrating that SOD1
binds more ANS molecules as the incubation period was prolonged.
The hydrophobic enhancement of SOD1 protein caused by
oxidation is consistent with that previously reported [40]. These
facts indicate the exposure of more SOD1 hydrophobic surfaces
that bind ANS regardless of presence of DNA.
Binding of Oxidized SOD1 Proteins to DNA
To understand the interactions between oxidized SOD1
proteins and DNA, we measured the binding parameters of the
oxidized SOD1 to DNA with isothermal titration calorimetry
(ITC). We have reported the equilibrium constant of ,10 mM for
the binding of WT SOD1 to double-stranded DNA (dsDNA) [47].
Here, we used 24-nt single-stranded DNA (ssDNA) instead of
linear or supercoiled dsDNA to inhibit the dsDNA-triggered
aggregation of oxidized SOD1 proteins. The length of 24-nt
ssDNA should be long enough for the binding of the oxidized
SOD1. In addition, utilization of the small ssDNA might be
favorable for understanding the driving forces of SOD1 to DNA.
Figure 3A shows the results from a typical ITC experiment in
which ssDNA was titrated into the oxidized SOD1-containing
solution. The data indicate that the binding of the oxidized SOD1
to DNA is an exothermic reaction with a large negative enthalpy
change of –27.6560.45 kcal/mol and a binding equilibrium
constant of ,100 nM, revealing that the strong binding between
the oxidized SOD1 proteins and ssDNA is mainly determined by
the electrostatic interactions. The binding stoichiometry was
determined to be 0.86, indicating that (1) each ssDNA molecule
may provide a single binding site for the oxidized SOD1, and (2)
the oxidized SOD1 proteins bound to the ssDNA may not
aggregate. However, an unfavorable entropy change was observed
during the binding of the oxidized SOD1 to ssDNA, which might
Figure 2. Comparison of ANS binding property of SOD1 in the
presence and absence of both Asc and DNA in 20 mM Tris-HCl
buffer (pH 7.4). A) Fluorescence spectra of 20 mM ANS added into the
mixtures containing 4 mM SOD1, 4 mM SOD1 and 7.5 mM ctDNA, or
4 mM SOD1, 7.5 mM ctDNA and 2 mM Asc. B) Change in the emission of
20 mM ANS added into the mixtures containing 4 mM SOD1 and 7.5 mM
ctDNA with Asc dose. C) Change in the emission of 20 mM ANS added
into the mixtures containing 4 mM SOD1, 2 mM Asc, and 7.5 mM ctDNA
with incubation time. Reactions were first incubated at 37uC for 2 h (A
and B) or 0–72 h (C), and then re-incubated for 10 min at 37uC after
addition of 20 mM ANS prior to measurement.
doi:10.1371/journal.pone.0012328.g002
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We also measured the DNA binding property of WT SOD1 under
the identical conditions, and the significant binding of WT SOD1
to ssDNA was not observed (Figure 3B), revealing that the
interference from the unmodified SOD1 with the binding of
modified SOD1 to ssDNA is negligible.
Acceleration Roles of DNA in the Aggregation of
Oxidized SOD1 Proteins
An in vitro study has indicated that either linear or supercoiled
DNAs acting as a template can dramatically accelerate the SOD1
aggregation under acidic conditions [33]. The enhancement in the
ANS binding indicates that the hydrophobicity of SOD1 was
enhanced because of both oxidation and presence of DNA under
neutral conditions (Figure 2A). Moreover, the oxidized SOD1
proteins were observed to have the higher affinity for DNA
compared to the unmodified SOD1 (Figure 3A). Thus, we wonder
if the DNA templates can promote aggregation of the oxidized
SOD1 proteins under the identical conditions (pH 7.4).
To examine the DNA-accelerated the aggregation of oxidized
SOD1 proteins in vitro, time courses of reactions of the oxidized
SOD1 proteins with DNA were monitored by dynamic light
scattering (DLS). The same test conditions were maintained in
controls containing Asc and either SOD1 or ctDNA. The DLS
data showed that aggregates were immediately generated upon
addition of ctDNA into the reactions containing both SOD1 and
Asc without stirring (Figure 4A). The average hydrodynamic
diameters of aggregates were dramatically increased to .1000 nm
over 20 min. The aggregates maintain slow growth after
incubation of 20 min. However, the significant aggregation of
oxidized SOD1 proteins without DNA was not observed over
incubation of 2 h, confirmed by right angle light scattering (RALS)
measurements performed for the samples only containing either
Asc and SOD1 or Asc and DNA (Figure S2). Indeed, the
incubation of 24–48 h without DNA has been reported to be
required to reach such the average diameter of 1000 nm for the
aggregates of oxidized SOD1 [40,42].
Then, the DNA dose dependence showed that the aggregation
of oxidized SOD1 proteins without DNA occurs only when its
concentration was $40 mM, as shown previously by RALS
measurements [40], but aggregates were immediately observed
to form from the reaction of 4 mM SOD1 and 2 mM Asc with
7.5 mM ctDNA (Figure 4B). In addition, we found by RALS
measurements that the sizes of aggregates are almost linearly
enhanced with ctDNA dose. Finally, the protein dose dependence
observed by fixing doses of Asc and ctDNA showed that 0–2 mM
SOD1 leads to the sharp increase, and larger SOD1 doses lead to
the linear and slow increase in aggregate size (Figure 4C).
Inhibition of the DNA-Triggered Aggregation of Oxidized
SOD1 Proteins
Examining effects of the reaction conditions including ionic
strength, guanidinium chloride (GdmCl) or chelating agents on the
DNA-triggered aggregation of oxidized SOD1 proteins could be in
favor of understanding the forces that drive the protein aggregation
under neutral conditions.
Firstly, probing the effect of ionic strength on aggregation can
provide an insight into the nature of interactions between proteins
and DNA. We have observed that interactions of SOD1 with DNA
are markedly affected by ionic strength [33,47]. Thus, the influence
of NaCl on the DNA-triggered aggregation of oxidized SOD1
proteins was monitored by RALS. The data showed that the
Figure 3. ITC analysis of oxidized SOD1 proteins binding to ssDNA. A) The upper panel shows the raw calorimetric data of the titration of
ssDNA (40 mM) into WT SOD1 (5 mM) at 25uC in the 20 mM Tris-HCl buffer (pH 7.4) containing 4 mM Asc, and the lower panel shows the
corresponding integrated injection heats, corrected for the heat of dilution. B) ITC data of the titration of ssDNA (40 mM) into SOD1 (5 mM) at 25uCi n
the 20 mM Tris-HCl buffer (pH 7.4) without Asc. All samples were incubated for 2 h at 37uC prior to titration under the identical conditions. The curve
in the lower figure represents the best least-squares fits to the one-site binding model.
doi:10.1371/journal.pone.0012328.g003
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For example, 150 (physiological concentration) and 800 mM NaCl
lead to reduction of 30% and 95% in aggregation degree,
respectively. This result is in line with that obtained with ITC
experiments, indicating that the binding of oxidized SOD1 proteins
to DNA is driven by electrostatic interactions between them.
The inhibition behavior monitored by RALS indicated that
1 M GdmCl leads to reduction of 97% in aggregation extent
(Figure 5B and 5C, left half). Moreover, the degradation
experiments show that the degradation of aggregates occurs
immediately upon addition of GdmCl, as indicated by appearance
of the DNA bands with slight smear in agarose gels (Figure 5C,
right half), well consistent with the fact that no SOD1 aggregate is
observed in the SDS-PAGE gels, revealing that the SOD1
aggregates are not resistant to protein denaturants including
GdmCl and SDS. The result suggests that the intermolecular
hydrophobic forces of oxidized SOD1 proteins are one of the
aggregation-driving forces. In addition, the inhibition experiments
performed with EDTA showed the appearance of the clear DNA
bands and almost complete inhibition of aggregation with
increasing EDTA dose (Figure 5D). This result suggests that the
oxidative aggregation must involve the copper on SOD1.
Morphology of DNA-Triggered Oxidized SOD1
Aggregates
In order to examine morphology of aggregates provided by the
oxidized SOD1 proteins in the presence of DNA under neutral
conditions, visualization of samples was performed under
transmission electron microscopy (TEM) without staining. The
DNA or SOD1 alone was first observed under TEM at pH 7.4 for
comparison. The lDNA was observed to represent in a typical
filament state (Figure 6A), and the SOD1 was in an amorphous
state on the copper grid due to the formation of SOD1 aggregates
caused by concentration of SOD1 during drying (Figure 6B).
One of the main aggregates observed under TEM in the
lDNA-triggered aggregation containing 2 mM Asc under neutral
conditions are the aggregate monomers consisted of a large
number of oxidized SOD1 molecules and one lDNA molecule
that is clearly visible here [33,59]. This spherical aggregate
monomer has an average diameter of 250–300 nm (Figure 6C). In
contrast, although the SOD1 can associate with DNA under
neutral conditions [47], any observable aggregation phenomenon
under the TEM is not found without Asc, as indicated with DSL in
examining the time courses of aggregation, revealing that Asc-
induced SOD1 oxidation is a key factor in the enhanced
aggregation propensity of WT SOD1. Moreover, incubating the
reactions consisted of SOD1 and Asc does not produce any
observable aggregate under the TEM in the absence of DNA.
These facts indicate that the presence of DNA plays a critical role
in Asc-induced oxidized SOD1 polymerization. In addition, the
co-existence of DNA and proteins in the aggregates has been
confirmed by fluorescent staining (ethidium bromide for DNA ,
thioflavin T/S for protein aggregates) experiments [33,59].
Discussion
The study presented here reported that three kinds of DNAs
tested significantly accelerate the aggregation of oxidized SOD1
Figure 4. Dependences of DNA-triggered aggregation of
oxidized SOD1 proteins on reaction conditions in 20 mM
Tris-HCl buffer (pH 7.4). A) Reactions without stirring were
incubated at 37uC for 0–120 min after addition of 7.5 mM ctDNA into
the mixtures containing 4 mM SOD1 and 2 mM Asc. B) For DNA dose
dependence, 0–75 mM ctDNA were added into the mixtures containing
4 mM SOD1 and 2 mM Asc were incubated at 37uC for 2 h. C) SOD1
dose dependence was observed by incubating reactions consisted of 0–
16 mM SOD1, 2 mM Asc, and 7.5 mM ctDNA at 37uC for 2 h.
doi:10.1371/journal.pone.0012328.g004
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conditions [33]. The tested SOD1 proteins were isolated from
human erythrocytes, and are highly relevant to aggregation, as
reported by three independent groups [54–56]. Although SOD1 is
known so far to be one of the most stable proteins, its
conformation and stability can be influenced by mutation or
oxidative modification, resulting in its monomerization, demetalli-
zation, increased susceptibility of disulfide bonds to reduction,
reduction in repulsive charges, and proneness to aggregation
[60,61]. Here, we find that the exposure of WT SOD1 to the Asc-
containing environment can also alter its stability, resulting in
monomerization, and exposure of more hydrophobic surfaces.
Oxidation is one of the factors that cause SOD1 aggregation
[40,42]. Considering evidence of oxidative damage in sporadic
ALS patients [62,63] and abundance and ubiquity of the enzyme
within cells [64], it seems plausible that SOD1 might constitute
targets of oxidative damage in ALS. It has been reported that
oxidative damage to SOD1 results in their dissociation into
monomers and monomer destabilization, and aggregation in vitro
[40]. The same phenomenon was observed in the Asc-induced
SOD1 oxidation, but the concentrations of the SOD1 tested were
nano- to micro-molar scale (Figure 4C), much less than its
physiological level of ,40 mM [40], and might fall in the
concentration range of mutant SOD1 proteins. In the study, the
enhanced hydrophobicity and gain of aggregation-prone propen-
sity are found to be insufficient for the protein aggregation, if the
protein does not reach the threshold concentration (40 mM here)
required for aggregation. This is supported by the fact that the
formation of oxidized SOD1 aggregates was not observed with the
DLS and TEM in the range of concentrations tested in the
absence of DNA-templated effect under identical conditions.
The ITC tests show that the binding of oxidized SOD1
proteins to DNA is enthalpy-driven and characterized by a high
binding affinity. This observation leads us to suggest that the
DNA binding neutralize the positive charges on SOD1 surfaces
that prevent from aggregation, and significantly increases the
local concentration of oxidized SOD1 proteins, resulting in a
higher SOD1 concentration on the surface of DNA than that in
bulk solution. Furthermore, it is observed that the more
hydrophobic surfaces of oxidized SOD1 molecules became more
solvent-accessible. Thus, DNA binding provides an avenue both
to acquire a local and high concentration enough to facilitate the
formation of aggregation-prone protein conformations and to
enable the protein aggregation.
Two current apparently disparate hypotheses on the toxic gain
of SOD1 functions may not be mutually exclusive when
considering two finding: (1) there is a clear relationship between
protein oxidation, hydrophobic enhancement, and DNA-triggered
aggregation, and (2) SOD1 oxidation or exposure to acidic
environments contributes to aggregation. Oxidation and acidic pH
can alter protein structures and hydrophobicity, but it is uncertain
if the repulsive charges on proteins can be reduced. According to
the above observed DNA-triggered aggregation of the oxidized
SOD1 proteins under neutral conditions, we found that the DNA
binding-mediated reduction in the opposite charges on oxidized
SOD1 protein surfaces provides an avenue to acquire the sufficient
local concentrations to enable the SOD1 aggregation. Further-
more, reduction in the repulsive charge facilitates appearance of
the intermolecular hydrophobic interactions of oxidized SOD1
proteins and formation of protein aggregates. Therefore, the
accelerating effect of DNA in aggregation of the oxidized SOD1
proteins might be a consequence of three effects: reduced
Figure 5. Inhibition of DNA-triggered aggregation of oxidized SOD1 proteins in 20 mM Tris-HCl buffer (pH 7.4). A) Effect of ionic
strength was observed by incubating reactions containing 4 mM SOD1, 2 mM Asc, and 7.5 mM ctDNA at 37uC for 2 h in the presence of 0–800 mM NaCl.
Here, the inhibition degree of aggregation is expressed by [(RALS)0– (RALS)NaCl]/(RALS)06100%, (RALS)0 and (RALS)NaCl represent RALS values in the
absence and in the presence of NaCl at each concentration, respectively. B) The inhibitory effect of GdmCl was monitored by RALS measurements.
Reactions containing 4 mM SOD1, 2 mM Asc, and 7.5 mM ctDNA were incubated at 37uC for 2 h in the presence of 0–6 M GdmCl. The disaggregation
degree of aggregation is expressed as (A). C) The disaggregation and inhibition of aggregates was monitored by agarose gel electrophoresis. The
aggregates were produced by incubating reactions containing 4 mM SOD1, 2 mM Asc, and 15 mM pBR322 DNA for 24 h at 37uC, and re-incubated for
1 min with 0–6 M GdmCl before loading onto gels. D) The inhibition of aggregation caused by EDTA was monitored by agarose gel electrophoresis.
4 mM SOD1 and 2 mM ascorbate were incubated for 2 h at 37uCw i t h1 5mM pBR322 DNA in the presence of 0–100 mM EDTA before loading onto gels.
doi:10.1371/journal.pone.0012328.g005
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concentrations.
In summary, the reactions of Asc with redox metals on
metalloproteins likely contribute to the redox state of cells that
may play a role in protein aggregation. Using the important
process of metalloenzyme-catalyzed oxidation, the aggregation of
oxidized SOD1 proteins at nano- to micro-molar levels in vitro is
accelerated by DNA. The process of DNA-triggered aggregation
of oxidized SOD1 proteins was proposed as follows: association of
the oxidized SOD1 proteins with DNA, reduction in the positive
charges that might involve the prevention of SOD1 proteins from
aggregation, enhancement in hydrophobicity, concentration of
oxidized SOD1 proteins along DNA, association each other of
DNA-bound oxidized SOD1 molecules, finally, formation of
protein aggregates by the hydrophobic interactions. Recently,
increasing evidence shows that indirect and direct interactions can
occur between SOD1 and DNA or RNA both inside and outside
cells [65–69]. Therefore, understanding the nucleic acid binding
property of SOD1 might be in favor of understanding the
intermolecular forces driving SOD1 aggregation, and provide a
plausible explanation for the SOD1-induced ALS.
Materials and Methods
Materials
Calf thymus DNA (ctDNA), wild type SOD1 (isolated from
human erythrocytes), ascorbate (Asc), ethidium bromide (EtBr), 8-
anilino-1-naphthalene-sulfonic acid (ANS), and guanidinium
chloride (GdmCl) were purchased from Sigma. The plasmid
pBR322 DNA and bacteriophage lDNA were purchased from
TaKaRa, the ssDNA (24-nt, 59-GGTCGGAGTCAACG-
GATTTGGTCG-39) was purchased from Invitrogen. Removal
of impurities from SOD1 samples was monitored by liquid
chromatography-electrospray ionization-mass spectrum on an
Agilent1100 Cap LC/MSD XCT mass spectrometer. Dimeric
SOD1 protein concentrations were estimated by the molar
extinction at 280 nm of 10,800 M
21cm
21 [70]. Unless otherwise
stated, DNA concentration was expressed in base pairs. All
samples were prepared using distilled water that had been passed
through a Millipore-Q ultrapurification system.
Asc-Mediated SOD1 Oxidation in vitro
First, to examine the Asc dose dependence of SOD1 oxidation,
0–8 mM Asc was added into solutions containing 10 mM SOD1,
and reactions were incubated at 37uC for 2 h in 20 mM Tris-HCl
buffer (pH 7.4).
Non-reducing sodium dodecyl sulfate-polyacrylamide gel elec-
trophoresis (SDS-PAGE) experiments were conducted on a 15%
polyacrylamide resolving gel with a 5% polyacrylamide stacking
gel. Samples were added 56loading buffer without b-mercapto-
ethanol (b-ME). The gels were run at constant voltage of 80 V and
stained by Coomassie Brilliant Blue R-250. Two-dimensional gel
electrophoresis (2-DE) was carried out using an Ettan IPGphor 3
isoelectric focusing (IEF) unit and an Ettan DALTsix electropho-
resis unit (GE Healthcare). IEF was performed with 7-cm
Immobiline DryStrips (immobilized pH gradient strips, GE
Figure 6. Visualization of aggregate and control samples under
TEM. The controls were 7.5 mM lDNA (A) and 4 mM SOD1 (B) and
incubated for 2 h at 37uC in the buffer (pH 7.4) containing 2 mM Asc
prior to observation. C) Aggregate monomers were produced by
incubating reactions containing 4 mM SOD1, 2 mM Asc and 7.5 mM
lDNA for 2 h at 37uC.
doi:10.1371/journal.pone.0012328.g006
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Proteins were visualized using Coomassie brilliant blue R-250 or
Plusone silver staining kit (Amersham Biosciences). To minimize
gel-to-gel variations, three 2-DE gels were run for the samples.
The silver-stained gels were scanned and analyzed with Image-
Master 2D Platinum 6.0 software (GE Healthcare). Isoelectric
points (pI) of spots were calculated according to the plot showing
pH as a function of distance.
Analysis of Hydrophobicity of Oxidized SOD1 Proteins in
the Presence of DNA
To examine changes in hydrophobicity of oxidized SOD1
proteins, the fluorescence property of ANS bound to oxidized
SOD1 proteins was examined on a Varian Cary Eclipse
spectrofluorometer. Aliquots (300 mL) containing (1) 4 mM
SOD1, (2) 7.5 mM ctDNA, (3) 4 mM SOD1 and 7.5 mM ctDNA,
or (4) 4 mM SOD1, 7.5 mM ctDNA and 0–4 mM Asc were first
incubated for 0–72 h at 37uC, and then re-incubated for 10 min
with 20 mM ANS in 20 mM Tris-HCl buffer (pH 7.4), before
measurement of fluorescence spectra between 450–650 nm
(excitation at 365 nm).
Binding Assay of Oxidized SOD1 Proteins to DNA
Isothermal titration calorimetry (ITC) was used to determine
the binding parameters of oxidized SOD1 proteins to DNA and
performed with a VP-ITC MicroCalorimeter. The samples were
incubated for 2 h in the 4 mM Asc-containing buffer at 37uC and
thoroughly degassed prior to titration. The sample cell was filled
with 5 mM oxidized SOD1 or WT SOD1, and the syringe was
filled with 40 mM ssDNA. The same buffer (20 mM Tris-HCl
containing 4 mM Asc, pH 7.4) was used in both the syringe and
the cell. The titration involved a single injection (1 mL) of and a
series of injections (2 mL) of ssDNA solutions into the SOD1
solution. Analysis was carried out using Microcal Origin Software.
Individual injections were integrated following manual adjustment
of the baselines. Dilution and mixing heats were determined from
separate control experiments or from the end point of the titration.
This value was subtracted prior to curve fitting using a one-site
model.
DNA-Triggered Aggregation of Oxidized SOD1 Proteins
in vitro
SOD1 at given doses was added into 20 mM Tris-HCl buffer
(pH 7.4) containing 2–4 mM Asc. To trigger aggregation, ctDNA,
lDNA or pBR322 DNA at given doses was added into the
mixtures. The control reactions were each of reactants, mixtures of
SOD1 with either Asc or DNA under identical conditions at each
level used in aggregation reactions.
To examine the influence of reaction conditions on the
oxidative aggregation, a series of experiments were carried out.
Firstly, time courses of aggregation were observed in 0–120 min,
for reaction consisting of 4 mM SOD1, 2 mM Asc and 7.5 mM
lDNA. Then, 0–75 mM ctDNA was incubated with 4 mM SOD1,
or 0–16 mM SOD1 was incubated with 7.5 mM ctDNA for 2 h in
the buffer containing 2 mM Asc for observations of either DNA or
SOD1 dose dependence. Finally, to recognize inhibition of SOD1
aggregation by ionic strength, GdmCl or EDTA, aggregation
mixtures (4 mM SOD1, 2 mM Asc, 7.5 mM ctDNA) were
incubated with 0–800 mM NaCl, 0–6 M GdmCl or 0–100 mM
EDTA for 2 h. To examine disaggregation, 0–6 M GdmCl was
added into SOD1 aggregates formed by incubation of the mixtures
(4 mM SOD1, 2 mM Asc, and 7.5 mM ctDNA) for 24 h. The
disaggregation reactions were incubated for 1 min at 37uC.
Analysis of DNA-Triggered Aggregation of Oxidized
SOD1 Proteins
The aggregation of oxidized SOD1 proteins with DNA was
monitored with both right angle light scattering (RALS), and
agarose gel electrophoresis. First, to determine the extent of SOD1
oxidative aggregation, RALS measurements were made at on the
Cary Eclipse spectrofluorometer for each sample and each control
(300 mL) according to the previously reported procedures [42].
Excitation and emission wavelengths were set all at 400 nm (band
pass 4 nm) according to the average diameters of aggregates
tested. Then, average hydrodynamic diameters of aggregates were
evaluated by DLS [42]. DLS data were collected at 25uCo na
HORIBA LB-550 dynamic light scattering particle size analyzer.
The average diameters and their distributions were recorded for
each sample and each control. Consecutive measurements (at least
200 times) were made with a cell of 2 mL for normalization
analysis. Each spectrum represents an average of ten accumula-
tions. For time courses, aliquots were taken from the aggregation
mixtures at each designed time point, and DLS values were
immediately recorded. In addition, DNA electrophoresis was
conducted on a 0.8% agarose gel. The DNA gel bands were
visualized by EtBr (0.5 mg/mL) staining.
Visualization of the DNA-Triggered Aggregation of
Oxidized SOD1 Proteins
Aggregates formed by the oxidized SOD1 proteins in the
presence of DNA were visualized with a Tecnai G220 transmission
electron microscope (TEM) [36]. Aliquots (5 mL) taken from
incubation of a mixture of SOD1, lDNA or pBR322 DNA, and
ascorbate at given concentrations for a given period at 37uC were
adsorbed onto a thin carbon film-coated copper electron
microscope grids (200-mesh), washed with the buffer, and air-
dried for 5 min, followed by direct observations with TEM. The
samples were not positively stained and directly imaged at 175 kV.
Digital images of aggregation species were captured for final
magnifications of 25–1,100,0006. All of these operations were also
carried out for both SOD1 and DNA controls.
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